Date | Time | Source | Announcement |
---|---|---|---|
16 May 2006 | 07:00 AM | US Appointment | |
15 May 2006 | 07:01 AM | Conference Webcast | |
10 May 2006 | 04:26 PM | Holding(s) in Company | |
26 Apr 2006 | 04:50 PM | Result of AGM | |
04 Apr 2006 | 07:00 AM | Merial Option Agreement | |
13 Mar 2006 | 07:01 AM | Boston Conference Webcast | |
01 Mar 2006 | 09:27 AM | Director/PDMR Shareholding | |
28 Feb 2006 | 07:00 AM | Preliminary Results | |
27 Feb 2006 | 10:06 AM | Positive Preclinical Data | |
10 Feb 2006 | 11:49 AM | Holding(s) in Company | |
23 Jan 2006 | 07:00 AM | New study data | |
12 Dec 2005 | 01:32 PM | Holding(s) in Company | |
15 Nov 2005 | 05:28 PM | Holding(s) in Company | |
15 Nov 2005 | 11:34 AM | Holding(s) in Company | |
15 Nov 2005 | 11:31 AM | Holding(s) in Company | |
15 Nov 2005 | 11:23 AM | Holding(s) in Company | |
14 Nov 2005 | 07:00 AM | Change of Adviser | |
09 Nov 2005 | 12:40 PM | Result of EGM | |
28 Oct 2005 | 03:09 PM | Director/PDMR Shareholding | |
25 Oct 2005 | 07:00 AM | Business Development Appt. | |
14 Oct 2005 | 11:23 AM | Fundraising | |
03 Oct 2005 | 07:00 AM | Research Appointment | |
28 Sep 2005 | 07:00 AM | Interim Results | |
27 Sep 2005 | 01:00 PM | Notice of Webcast | |
20 Sep 2005 | 07:00 AM | Positive Phase II Data | |
19 Sep 2005 | 07:00 AM | Notice of Results | |
12 Sep 2005 | 07:00 AM | New Study Data | |
31 Aug 2005 | 07:01 AM | Positive Vaccine Result | |
31 Aug 2005 | 07:00 AM | Appointment of Nomad/Broker | |
10 May 2005 | 11:03 AM | Holding(s) in Company | |
10 May 2005 | 11:00 AM | Holding(s) in Company | |
04 May 2005 | 01:23 PM | Result of AGM | |
25 Apr 2005 | 07:00 AM | Change of Registered Office | |
20 Apr 2005 | 11:17 AM | Result of EGM | |
18 Apr 2005 | 07:00 AM | Rhinitis IND | |
13 Apr 2005 | 10:38 AM | Holding(s) in Company | |
30 Mar 2005 | 03:50 PM | Holding(s) in Company | |
29 Mar 2005 | 10:29 AM | Holding(s) in Company | |
29 Mar 2005 | 09:52 AM | Holding(s) in Company | |
23 Mar 2005 | 07:00 AM | GBP9.5 million Fundraising | |
02 Mar 2005 | 07:00 AM | Final Results | |
28 Feb 2005 | 07:00 AM | New Agreement | |
24 Feb 2005 | 04:14 PM | Notice of Results | |
18 Jan 2005 | 07:00 AM | Patent Granted | |
10 Jan 2005 | 07:00 AM | Appt of Development Director | |
07 Dec 2004 | 07:00 AM | Eye Study Results | |
29 Sep 2004 | 07:00 AM | Interim Report to 30 June 04 | |
02 Aug 2004 | 07:00 AM | First Day of Dealings on AIM | |
17 Aug 2001 | 10:24 AM | Result of EGM | |
17 Aug 2001 | 07:00 AM | Statement re Suspension |
Nanoco Group is a nanomaterial production and licensing company that specializes in cadmium-free quantum dots and other semiconductor nanomaterials. Nanoco's products include cadmium-free quantum dots and HEATWAVE quantum dots. CFQD quantum dots are used for OLED and µLED color conversion, QD-EL, and security. HEATWAVE quantum dots are used in cameras and image sensors.
Nanoco operates in the United Kingdom, Europe, Asia, and the United States.
Nanoco's headquarters are in Runcorn, UK, where the company's R&D and manufacturing activities are also based.
Nanoco share price listed at 127p in 2004 under the ticker NANO.